Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Januel

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Neurology|June 7, 2021
Fine Particulate Matter Related to Multiple Sclerosis Relapse in Young PatientsEdouard Januel, Boris Dessimond, Augustin Colette, et al.
Acta Neurologica Belgica|July 15, 2020
Anti-PD1-R checkpoint inhibitor related severe relapsing myelitisEdouard Januel, Louis Perol, Lionel Arrivé, et al.
Neurology|April 14, 2025
Updated Multiple Sclerosis Incidence in France, 2011-2021Octave Guinebretiere, Chloe Pierret, Quentin Calonge, et al.
Annals of Intensive Care|January 7, 2024
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacksEdouard Januel, Vincent Brochard, Loïc Le Guennec, et al.
Clinical and Experimental Rheumatology|October 23, 2020
Primary Sjögren's syndrome: central and peripheral nervous system involvementsArsène Mekinian, Juliette Tennenbaum, Constance Lahuna, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2018
Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?Edouard Januel, Guillaume Martin-Blondel, Cédric Lamirel, et al.
Epilepsia|September 3, 2025
Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11-year nationwide studyQuentin Calonge, Aurélie Hanin, Edouard Januel, et al.
Journal of Neurology|April 20, 2026
Optic chiasmal neuritis: clinical features, aetiologies, MRI patterns and prognosis in a real-world cohortVincent Brochard, Augustin Lecler, Edouard Januel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis opticaEdouard Januel, Jérôme De Seze, Patrick Vermersch, et al.
European Journal of Neurology|June 13, 2023
Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralizationCéline Louapre, Lisa Belin, Stéphane Marot, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|June 7, 2021
Fine Particulate Matter Related to Multiple Sclerosis Relapse in Young PatientsEdouard Januel, Boris Dessimond, Augustin Colette, et al.
Acta Neurologica Belgica|July 15, 2020
Anti-PD1-R checkpoint inhibitor related severe relapsing myelitisEdouard Januel, Louis Perol, Lionel Arrivé, et al.
Neurology|April 14, 2025
Updated Multiple Sclerosis Incidence in France, 2011-2021Octave Guinebretiere, Chloe Pierret, Quentin Calonge, et al.
Annals of Intensive Care|January 7, 2024
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacksEdouard Januel, Vincent Brochard, Loïc Le Guennec, et al.
Clinical and Experimental Rheumatology|October 23, 2020
Primary Sjögren's syndrome: central and peripheral nervous system involvementsArsène Mekinian, Juliette Tennenbaum, Constance Lahuna, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 2018
Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?Edouard Januel, Guillaume Martin-Blondel, Cédric Lamirel, et al.
Epilepsia|September 3, 2025
Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11-year nationwide studyQuentin Calonge, Aurélie Hanin, Edouard Januel, et al.
Journal of Neurology|April 20, 2026
Optic chiasmal neuritis: clinical features, aetiologies, MRI patterns and prognosis in a real-world cohortVincent Brochard, Augustin Lecler, Edouard Januel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis opticaEdouard Januel, Jérôme De Seze, Patrick Vermersch, et al.
European Journal of Neurology|June 13, 2023
Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralizationCéline Louapre, Lisa Belin, Stéphane Marot, et al.
Pageof 3